{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T20:05:59Z","timestamp":1795291559362,"version":"4.10.3"},"reference-count":71,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>COVID-19\u2013related critical and acute illness is associated with an increased risk of venous thromboembolism (VTE). These evidence-based recommendations of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in decisions about using anticoagulation for thromboprophylaxis for patients with COVID-19\u2013related critical illness; patients with COVID-19\u2013related acute illness; and those being discharged from the hospital, who do not have suspected or confirmed VTE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>ASH formed a multidisciplinary panel, including patient representatives. The Michael G. DeGroote Cochrane Canada and MacGRADE Centres at McMaster University supported guideline development, including performing systematic reviews (up to June 2023). The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The panel used the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach to assess certainty in the evidence and make recommendations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This is an executive summary of 3 updated recommendations that have been published, which concludes the living phase of the guidelines. For patients with COVID-19\u2013related critical illness, the panel issued conditional recommendations suggesting (a) prophylactic-intensity over therapeutic-intensity anticoagulation and (b) prophylactic-intensity over intermediate-intensity anticoagulation. For patients with COVID-19\u2013related acute illness, conditional recommendations were suggested (a) prophylactic-intensity over intermediate-intensity anticoagulation, and (b) therapeutic-intensity over prophylactic-intensity anticoagulation. The panel issued a conditional recommendation suggesting against the use of postdischarge anticoagulant thromboprophylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These conditional recommendations were made based on low or very low certainty in the evidence, underscoring the need for additional, high-quality, randomized controlled trials for patients with COVID-19.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024014219","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T18:32:57Z","timestamp":1729621977000},"page":"1247-1260","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":17,"title":["American Society of Hematology living guidelines on use of anticoagulation for thromboprophylaxis for patients with COVID-19: executive summary"],"prefix":"10.1182","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3806-3245","authenticated-orcid":false,"given":"Deborah M.","family":"Siegal","sequence":"first","affiliation":[{"name":"1Department of Medicine and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2745-8057","authenticated-orcid":false,"given":"Eric K.","family":"Tseng","sequence":"additional","affiliation":[{"name":"2Division of Hematology\/Oncology, St Michael\u2019s Hospital, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3211-8479","authenticated-orcid":false,"given":"Holger J.","family":"Sch\u00fcnemann","sequence":"additional","affiliation":[{"name":"3Department of Health Research Methods, Evidence, and Impact, Department of Medicine, Michael G. DeGroote Cochrane Canada Centre, and McMaster GRADE Centre, McMaster University, Hamilton, ON, Canada"},{"name":"4Institut f\u00fcr Evidenz in der Medizin, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantep","family":"Angchaisuksiri","sequence":"additional","affiliation":[{"name":"5Division of Hematology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3595-5697","authenticated-orcid":false,"given":"Adam","family":"Cuker","sequence":"additional","affiliation":[{"name":"6Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Dane","sequence":"additional","affiliation":[{"name":"7Department of Pharmacy, The Johns Hopkins Hospital, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"DeSancho","sequence":"additional","affiliation":[{"name":"8Division of Hematology-Oncology, Department of Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Diuguid","sequence":"additional","affiliation":[{"name":"9Division of Hematology, College of Physicians and Surgeons, Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5853-6906","authenticated-orcid":false,"given":"Daniel O.","family":"Griffin","sequence":"additional","affiliation":[{"name":"10Division of Infectious Diseases, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY"},{"name":"11Optum Tristate, Lake Success, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9961-0754","authenticated-orcid":false,"given":"Frederikus A.","family":"Klok","sequence":"additional","affiliation":[{"name":"12Department of Medicine, Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-3948","authenticated-orcid":false,"given":"Alfred Ian","family":"Lee","sequence":"additional","affiliation":[{"name":"13Section of Hematology, Yale School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Neumann","sequence":"additional","affiliation":[{"name":"14Escuela de Medicina, Facultad de Medicina y Ciencia, Universidad San Sebastian, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Pai","sequence":"additional","affiliation":[{"name":"15Division of Hematology and Oncology, Kaiser Permanente, Oakland, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Righini","sequence":"additional","affiliation":[{"name":"16Division of Angiology and Hemostasis, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0433-7845","authenticated-orcid":false,"given":"Kristen M.","family":"Sanfilippo","sequence":"additional","affiliation":[{"name":"17Division of Hematology, Washington University School of Medicine St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0794-5851","authenticated-orcid":false,"given":"Deirdra R.","family":"Terrell","sequence":"additional","affiliation":[{"name":"18Department of Biostatistics and Epidemiology, Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3444-8618","authenticated-orcid":false,"given":"Elie A.","family":"Akl","sequence":"additional","affiliation":[{"name":"19Department of Internal Medicine, American University of Beirut, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyad","family":"Al Jabiri","sequence":"additional","affiliation":[{"name":"20Faculty of Medicine, University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan","family":"Al Jabiri","sequence":"additional","affiliation":[{"name":"21Division of Hospital Medicine, Washington University in St. Louis, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"Barbara","sequence":"additional","affiliation":[{"name":"22Canadian Agency for Drugs and Technologies in Health, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0128-903X","authenticated-orcid":false,"given":"Antonio","family":"Bognanni","sequence":"additional","affiliation":[{"name":"23Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada Centre, and McMaster GRADE Centre, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad Bou","family":"Akl","sequence":"additional","affiliation":[{"name":"24Faculty of Medicine, American University of Beirut School of Medicine, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5046-598X","authenticated-orcid":false,"given":"Mary","family":"Boulos","sequence":"additional","affiliation":[{"name":"25Postgraduate Medical Education, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-9900","authenticated-orcid":false,"given":"Romina","family":"Brignardello-Petersen","sequence":"additional","affiliation":[{"name":"26Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Chan","sequence":"additional","affiliation":[{"name":"27McMaster GRADE Centre, McMaster University Medical Centre, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5512-0091","authenticated-orcid":false,"given":"Rana","family":"Charide","sequence":"additional","affiliation":[{"name":"26Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7737-4914","authenticated-orcid":false,"given":"Luis E.","family":"Colunga-Lozano","sequence":"additional","affiliation":[{"name":"28Department of Clinical Medicine, Health Science Center, Universidad de Guadalajara, Guadalajara, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6854-0156","authenticated-orcid":false,"given":"Karin","family":"Dearness","sequence":"additional","affiliation":[{"name":"29Library Services, St Joseph\u2019s Healthcare Hamilton, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2498-1697","authenticated-orcid":false,"given":"Andrea J.","family":"Darzi","sequence":"additional","affiliation":[{"name":"23Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada Centre, and McMaster GRADE Centre, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6042-361X","authenticated-orcid":false,"given":"Heba","family":"Hussein","sequence":"additional","affiliation":[{"name":"30Department of Oral Medicine, Oral Diagnosis, and Periodontology, Faculty of Dentistry, Cairo University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5167-4246","authenticated-orcid":false,"given":"Samer G.","family":"Karam","sequence":"additional","affiliation":[{"name":"23Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada Centre, and McMaster GRADE Centre, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Kolb","sequence":"additional","affiliation":[{"name":"23Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada Centre, and McMaster GRADE Centre, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Mansour","sequence":"additional","affiliation":[{"name":"31University of Kansas Medical Center, University of Kansas, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7577-7963","authenticated-orcid":false,"given":"Gian Paolo","family":"Morgano","sequence":"additional","affiliation":[{"name":"23Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada Centre, and McMaster GRADE Centre, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2131-3711","authenticated-orcid":false,"given":"Rami Z.","family":"Morsi","sequence":"additional","affiliation":[{"name":"32Department of Neurology, University of Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Muti-Sch\u00fcnemann","sequence":"additional","affiliation":[{"name":"33Department of Emergency Medicine, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-3613","authenticated-orcid":false,"given":"Menatalla K.","family":"Nadim","sequence":"additional","affiliation":[{"name":"34Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0141-3718","authenticated-orcid":false,"given":"Atefeh","family":"Noori","sequence":"additional","affiliation":[{"name":"26Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"},{"name":"35Division of Plastic, Reconstructive and Aesthetic Surgery, Hand Program, University Health Network, Toronto Western Hospital, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binu A.","family":"Philip","sequence":"additional","affiliation":[{"name":"23Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada Centre, and McMaster GRADE Centre, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1643-5386","authenticated-orcid":false,"given":"Thomas","family":"Piggott","sequence":"additional","affiliation":[{"name":"26Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"},{"name":"36Department of Family Medicine, Queen\u2019s University, Kingston, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9572-9106","authenticated-orcid":false,"given":"Yuan","family":"Qiu","sequence":"additional","affiliation":[{"name":"37Department of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yetiani Roldan","family":"Benitez","sequence":"additional","affiliation":[{"name":"26Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Finn","family":"Sch\u00fcnemann","sequence":"additional","affiliation":[{"name":"38Asklepios Klinik Wandsbek, Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6257-4806","authenticated-orcid":false,"given":"Adrienne","family":"Stevens","sequence":"additional","affiliation":[{"name":"23Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada Centre, and McMaster GRADE Centre, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6134-9140","authenticated-orcid":false,"given":"Karla","family":"Solo","sequence":"additional","affiliation":[{"name":"23Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada Centre, and McMaster GRADE Centre, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6576-1650","authenticated-orcid":false,"given":"Wojtek","family":"Wiercioch","sequence":"additional","affiliation":[{"name":"23Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada Centre, and McMaster GRADE Centre, McMaster University, Hamilton, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2091-0875","authenticated-orcid":false,"given":"Reem A.","family":"Mustafa","sequence":"additional","affiliation":[{"name":"39Division of Nephrology, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robby","family":"Nieuwlaat","sequence":"additional","affiliation":[{"name":"23Department of Health Research Methods, Evidence, and Impact, Michael G. DeGroote Cochrane Canada Centre, and McMaster GRADE Centre, McMaster University, Hamilton, ON, Canada"},{"name":"31University of Kansas Medical Center, University of Kansas, Kansas City, KS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7","key":"2025031215221141400_bib1","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/rth2.12439","article-title":"Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis","volume":"4","author":"Nopp","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"12","key":"2025031215221141400_bib2","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1055\/s-0040-1715841","article-title":"Coagulopathy and thrombosis as a result of severe COVID-19 infection: a microvascular focus","volume":"120","author":"Katneni","year":"2020","journal-title":"Thromb Haemost"},{"issue":"17","key":"2025031215221141400_bib3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.120.050354","article-title":"Severe COVID-19 is a microvascular disease","volume":"142","author":"Lowenstein","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"2025031215221141400_bib4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.chest.2020.11.005","article-title":"Incidence of VTE and bleeding among hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis","volume":"159","author":"Jimenez","year":"2021","journal-title":"Chest"},{"issue":"7","key":"2025031215221141400_bib5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines International Network: principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Schunemann","year":"2015","journal-title":"Ann Intern Med"},{"issue":"7","key":"2025031215221141400_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-156-7-201204030-00009","article-title":"Guidelines International Network: toward international standards for clinical practice guidelines","volume":"156","author":"Qaseem","year":"2012","journal-title":"Ann Intern Med"},{"key":"2025031215221141400_bib7","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines","year":"2011"},{"key":"2025031215221141400_bib8","doi-asserted-by":"crossref","first-page":"i2089","DOI":"10.1136\/bmj.i2089","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"key":"2025031215221141400_bib9","doi-asserted-by":"crossref","first-page":"i2016","DOI":"10.1136\/bmj.i2016","article-title":"GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: introduction","volume":"353","author":"Alonso-Coello","year":"2016","journal-title":"BMJ"},{"issue":"1","key":"2025031215221141400_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6963-4-38","article-title":"Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches The GRADE Working Group","volume":"4","author":"Atkins","year":"2004","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"2025031215221141400_bib11","first-page":"677","article-title":"Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations","volume":"169","author":"Schunemann","year":"2003","journal-title":"CMAJ"},{"key":"2025031215221141400_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT","volume":"81","author":"Schunemann","year":"2017","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"4","key":"2025031215221141400_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"7650","key":"2025031215221141400_bib14","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"3","key":"2025031215221141400_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/bloodadvances.2020003763","article-title":"American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv"},{"issue":"20","key":"2025031215221141400_bib16","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/bloodadvances.2021005493","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients","volume":"5","author":"Cuker","year":"2021","journal-title":"Blood Adv"},{"issue":"2","key":"2025031215221141400_bib17","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/bloodadvances.2021005945","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis","volume":"6","author":"Cuker","year":"2022","journal-title":"Blood Adv"},{"issue":"17","key":"2025031215221141400_bib18","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1182\/bloodadvances.2022007561","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients","volume":"6","author":"Cuker","year":"2022","journal-title":"Blood Adv"},{"issue":"17","key":"2025031215221141400_bib19","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/bloodadvances.2022007940","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients","volume":"6","author":"Cuker","year":"2022","journal-title":"Blood Adv"},{"key":"2025031215221141400_bib20","unstructured":"ASH Guidelines on the Use of Anticoagulation in Patients With COVID-19. ASH. 2020. Accessed 4 March 2024. https:\/\/www.hematology.org\/education\/clinicians\/guidelines-and-quality-care\/clinical-practice-guidelines\/venous-thromboembolism-guidelines\/ash-guidelines-on-use-of-anticoagulation-in-patients-with-covid-19."},{"key":"2025031215221141400_bib21","unstructured":"Johns Hopkins University School of Medicine\n          . Coronavirus Resource Center. Johns Hopkins University School of Medicine. 2020. Accessed 4 March 2024. https:\/\/coronavirus.jhu.edu\/map.html."},{"issue":"7","key":"2025031215221141400_bib22","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/jth.14849","article-title":"Thromboinflammation and the hypercoagulability of COVID-19","volume":"18","author":"Connors","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"issue":"23","key":"2025031215221141400_bib23","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1182\/blood.2020006000","article-title":"COVID-19 and its implications for thrombosis and anticoagulation","volume":"135","author":"Connors","year":"2020","journal-title":"Blood"},{"issue":"8","key":"2025031215221141400_bib24","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol"},{"issue":"11","key":"2025031215221141400_bib25","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.2020007938","article-title":"Postdischarge thrombosis and hemorrhage in patients with COVID-19","volume":"136","author":"Patell","year":"2020","journal-title":"Blood"},{"issue":"20","key":"2025031215221141400_bib26","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1182\/blood.2020010529","article-title":"Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry","volume":"137","author":"Giannis","year":"2021","journal-title":"Blood"},{"issue":"4","key":"2025031215221141400_bib27","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.chest.2021.07.025","article-title":"COVID-19 and risk of VTE in ethnically diverse populations","volume":"160","author":"Go","year":"2021","journal-title":"Chest"},{"issue":"2","key":"2025031215221141400_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/rth2.12486","article-title":"Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19","volume":"5","author":"Spyropoulos","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"2025031215221141400_bib29","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s11239-021-02504-5","article-title":"External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19","volume":"52","author":"Goldin","year":"2021","journal-title":"J\u00a0Thromb Thrombolysis"},{"issue":"10","key":"2025031215221141400_bib30","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/jth.15463","article-title":"The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19","volume":"19","author":"Li","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"2025031215221141400_bib31","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1182\/bloodadvances.2020001755","article-title":"A\u00a0user guide to the American Society of Hematology clinical practice guidelines","volume":"4","author":"Izcovich","year":"2020","journal-title":"Blood Adv"},{"issue":"9","key":"2025031215221141400_bib32","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/jth.15450","article-title":"Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: a multi-center, open-label, randomized controlled trial","volume":"19","author":"Perepu","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"6","key":"2025031215221141400_bib33","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/jamainternmed.2023.0456","article-title":"Effects of standard-dose prophylactic, high-dose prophylactic, and therapeutic anticoagulation in patients with hypoxemic COVID-19 pneumonia: the ANTICOVID Randomized Clinical Trial","volume":"183","author":"Labbe","year":"2023","journal-title":"JAMA Intern Med"},{"issue":"16","key":"2025031215221141400_bib34","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/jama.2021.4152","article-title":"Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION Randomized Clinical Trial","volume":"325","author":"Sadeghipour","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"2025031215221141400_bib35","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jamainternmed.2021.6203","article-title":"Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID Randomized Clinical Trial","volume":"181","author":"Spyropoulos","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"10","key":"2025031215221141400_bib36","first-page":"1032","article-title":"Comparison of the effect of unfractionated heparin and enoxaparin sodium at different doses on the course of COVID-19-associated coagulopathy","volume":"11","author":"Oliynyk","year":"2021","journal-title":"Life (Basel)"},{"key":"2025031215221141400_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.thromres.2021.12.003","article-title":"Tissue plasminogen activator for the treatment of adults with critical COVID-19: a pilot randomized clinical trial","volume":"216","author":"Rashidi","year":"2022","journal-title":"Thromb Res"},{"key":"2025031215221141400_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.thromres.2020.09.026","article-title":"Therapeutic versus prophylactic anticoagulation for severe COVID-19: a randomized phase II clinical trial (HESACOVID)","volume":"196","author":"Lemos","year":"2020","journal-title":"Thromb Res"},{"issue":"9","key":"2025031215221141400_bib39","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with COVID-19","volume":"385","author":"The REMAP-CAP ACTIV-4a and ATTACC Investigators","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"2025031215221141400_bib40","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/CIRCULATIONAHA.122.061533","article-title":"Anticoagulation and antiplatelet therapy for prevention of venous and arterial thrombotic events in critically ill patients with COVID-19: COVID-PACT","volume":"146","author":"Bohula","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"2025031215221141400_bib41","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/jth.15310","article-title":"Bleeding risk by intensity of anticoagulation in critically ill patients with COVID-19: a retrospective cohort study","volume":"19","author":"Halaby","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"12","key":"2025031215221141400_bib42","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s00134-013-3044-3","article-title":"Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis","volume":"39","author":"Lauzier","year":"2013","journal-title":"Intensive Care Med"},{"issue":"6 suppl","key":"2025031215221141400_bib43","doi-asserted-by":"crossref","first-page":"257S","DOI":"10.1378\/chest.08-0674","article-title":"Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Schulman","year":"2008","journal-title":"Chest"},{"issue":"23","key":"2025031215221141400_bib44","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1161\/01.CIR.0000077530.53367.E9","article-title":"Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin","volume":"107","author":"Anand","year":"2003","journal-title":"Circulation"},{"issue":"6","key":"2025031215221141400_bib45","first-page":"750","article-title":"Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses","volume":"84","author":"Koch","year":"1997","journal-title":"Br J Surg"},{"key":"2025031215221141400_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2017.04.011","article-title":"Adjusted value of thromboprophylaxis in hospitalized obese patients: a comparative study of two regimens of enoxaparin: the ITOHENOX study","volume":"155","author":"Miranda","year":"2017","journal-title":"Thromb Res"},{"issue":"3","key":"2025031215221141400_bib47","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.thromres.2009.02.003","article-title":"Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-ill patients","volume":"125","author":"Rondina","year":"2010","journal-title":"Thromb Res"},{"key":"2025031215221141400_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2016.05.026","article-title":"Determining the safety of enoxaparin prophylaxis in critically ill patients with severe renal insufficiency - the PACER pilot study","volume":"144","author":"Castellucci","year":"2016","journal-title":"Thromb Res"},{"issue":"16","key":"2025031215221141400_bib49","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1001\/archinte.168.16.1805","article-title":"Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study","volume":"168","author":"Douketis","year":"2008","journal-title":"Arch Intern Med"},{"issue":"4","key":"2025031215221141400_bib50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1160\/TH06-09-0513","article-title":"Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function: a comparative pharmacokinetic study","volume":"97","author":"Mahe","year":"2007","journal-title":"Thromb Haemost"},{"issue":"6","key":"2025031215221141400_bib51","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med"},{"issue":"19","key":"2025031215221141400_bib52","first-page":"5632","article-title":"Efficacy and safety of tinzaparin in prophylactic, intermediate and therapeutic doses in non-critically ill patients hospitalized with COVID-19: the PROTHROMCOVID Randomized Controlled Trial","volume":"11","author":"Munoz-Rivas","year":"2022","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"2025031215221141400_bib53","doi-asserted-by":"crossref","first-page":"e13735","DOI":"10.1111\/eci.13735","article-title":"Enoxaparin for thromboprophylaxis in hospitalized COVID-19 patients: the X-COVID-19 Randomized Trial","volume":"52","author":"Morici","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"2025031215221141400_bib54","doi-asserted-by":"crossref","first-page":"n2400","DOI":"10.1136\/bmj.n2400","article-title":"Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID Randomised Clinical Trial","volume":"375","author":"Sholzberg","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"2025031215221141400_bib55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/a-1667-7534","article-title":"Therapeutic versus prophylactic bemiparin in hospitalized patients with nonsevere COVID-19 pneumonia (BEMICOP study): an open-label, multicenter, randomized, controlled trial","volume":"122","author":"Marcos-Jubilar","year":"2022","journal-title":"Thromb Haemost"},{"issue":"9","key":"2025031215221141400_bib56","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with COVID-19","volume":"385","author":"The ATTACC, ACTIV-4a, and REMAP-CAP Investigators","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"10291","key":"2025031215221141400_bib57","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(21)01203-4","article-title":"Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial","volume":"397","author":"Lopes","year":"2021","journal-title":"Lancet"},{"key":"2025031215221141400_bib58","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejim.2022.01.031","article-title":"Efficacy and safety of therapeutic vs. prophylactic bemiparin in noncritically ill patients with COVID-19 pneumonia","volume":"99","author":"Varona","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"18","key":"2025031215221141400_bib59","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2023.02.041","article-title":"Randomized trial of anticoagulation strategies for noncritically ill patients hospitalized with COVID-19","volume":"81","author":"Stone","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"2025031215221141400_bib60","doi-asserted-by":"crossref","first-page":"e12712","DOI":"10.1002\/rth2.12712","article-title":"Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID-19: the Swiss COVID-HEP randomized clinical trial","volume":"6","author":"Blondon","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"2025031215221141400_bib61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/M22-3350","article-title":"Effect of thromboprophylaxis on clinical outcomes after COVID-19 hospitalization","volume":"176","author":"Wang","year":"2023","journal-title":"Ann Intern Med"},{"issue":"10319","key":"2025031215221141400_bib62","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(21)02392-8","article-title":"Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial","volume":"399","author":"Ramacciotti","year":"2022","journal-title":"Lancet"},{"issue":"sup1","key":"2025031215221141400_bib63","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/00325481.2021.1876387","article-title":"Post-hospital discharge venous thromboembolism prophylaxis in medically ill patients","volume":"133","author":"Berkman","year":"2021","journal-title":"Postgrad Med"},{"issue":"10","key":"2025031215221141400_bib64","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/jth.13783","article-title":"Effect of extended-duration thromboprophylaxis on venous thromboembolism and major bleeding among acutely ill hospitalized medical patients: a bivariate analysis","volume":"15","author":"Chi","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"23","key":"2025031215221141400_bib65","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1110899","article-title":"Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients","volume":"365","author":"Goldhaber","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"2025031215221141400_bib66","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.jtha.2024.02.011","article-title":"2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19","volume":"22","author":"Schulman","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"issue":"3","key":"2025031215221141400_bib67","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.chest.2020.05.559","article-title":"Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST Guideline and Expert Panel Report","volume":"158","author":"Moores","year":"2020","journal-title":"Chest"},{"key":"2025031215221141400_bib68","year":"2021"},{"issue":"7","key":"2025031215221141400_bib69","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/cvr\/cvab343","article-title":"ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up","volume":"118","author":"Task Force for the management of COVID-19 of the European Society of Cardiology","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"1","key":"2025031215221141400_bib70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.chest.2022.02.006","article-title":"Thromboprophylaxis in patients with COVID-19: a brief update to the CHEST Guideline and Expert Panel Report","volume":"162","author":"Moores","year":"2022","journal-title":"Chest"},{"issue":"15","key":"2025031215221141400_bib71","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2021.02.035","article-title":"Recent randomized trials of antithrombotic therapy for patients with COVID-19: JACC State-of-the-Art Review","volume":"77","author":"Talasaz","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/6\/1247\/2359013\/blooda_adv-2024-014219-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/9\/6\/1247\/2359013\/blooda_adv-2024-014219-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:22:39Z","timestamp":1741778559000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/9\/6\/1247\/518290\/American-Society-of-Hematology-living-guidelines"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,3,25]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024014219","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]}}}